Serum angiotensin converting enzyme activity and response to angiotensin I in horses.
Abstract: The activity of serum angiotensin converting enzyme (ACE) for healthy horses was 64 +/- 13 mUnits/ml. In vitro, equine serum ACE was sensitive to the following inhibitors (IC50): enalapril (570 nM or 215 ng/ml), captopril (190 nM or 41.3 ng/ml), and enalaprilat (6 nM or 2.1 ng/ml). The intravenous (i.v.) administration of angiotensin I to six healthy horses produced a dose proportional pressor response. The maximal increase in mean arterial pressure over baseline values was 65.6 mmHg at angiotensin I doses of 500 ng/kg bodyweight (bwt). The attenuation of this response to angiotensin I was further demonstrated in a single horse by the prior administration of enalaprilat at an i.v. dose of 8.71 micrograms/kg bwt.
Publication Date: 1989-06-01 PubMed ID: 9118114DOI: 10.1111/j.2042-3306.1989.tb05662.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This study investigates serum angiotensin converting enzyme (ACE) activity in horses and the blood pressure response following administration of Angiotensin I. The research indicates that the activity of ACE in healthy horses can be reduced through inhibitors such as enalapril, captopril, and enalaprilat, and these inhibitors also dampen the pressor response to Angiotensin I dosing.
Understanding Serum Angiotensin Converting Enzyme Activity
- Serum angiotensin converting enzyme (ACE) is an enzyme that plays a crucial role in the renin-angiotensin system, which regulates blood pressure and fluid balance in the body. High activity levels of this enzyme can lead to elevated blood pressure.
- The study establishes the average ACE activity for healthy horses as 64 +/- 13 mUnits/ml, which serves as the baseline level against which the activity of ACE inhibitors is evaluated.
Sensitivity to ACE Inhibitors
- Enalapril, captopril, and enalaprilat are substances known to inhibit ACE, thereby reducing its activity. In this study, the horses’ serum ACE showed sensitivity to these inhibitors with varying levels of IC50. The IC50 is a measure of the effectiveness of a substance in inhibiting a specific biological or biochemical function. The lower the IC50 value, the less amount of a drug is needed to inhibit half of the enzyme activity, making it more effective.
- Enalaprilat, with an IC50 of just 6 nM (2.1 ng/ml), is the most potent inhibitor of the three substances tested.
Angiotensin I Injection and Blood Pressure Response
- Angiotensin I is a hormone that can increase blood pressure. The intravenous administration of angiotensin I to the healthy horses caused a dose-proportional rise in blood pressure. At the highest dose of 500 ng/kg body weight, the average increased in arterial pressure was 65.6 mmHg over baseline levels.
The Role of Enalaprilat in Attenuating Pressor Response
- The study further established the role of enalaprilat in mitigating the blood pressure response to Angiotensin I. When a single horse was administered enalaprilat prior to an Angiotensin I injection, the response showed apparent attenuation. This supports the notion that ACE inhibitor drugs such as enalaprilat can effectively reduce the blood pressure response, and thus potentially control instances of elevated blood pressure in horses.
Cite This Article
APA
Tillman LG, Moore JN.
(1989).
Serum angiotensin converting enzyme activity and response to angiotensin I in horses.
Equine Vet J Suppl(7), 80-83.
https://doi.org/10.1111/j.2042-3306.1989.tb05662.x Publication
Researcher Affiliations
- Department of Pharmaceutics, College of Pharmacy, University of Georgia, Athens 30602, USA.
MeSH Terms
- Angiotensin I / administration & dosage
- Angiotensin I / pharmacology
- Angiotensin-Converting Enzyme Inhibitors / administration & dosage
- Angiotensin-Converting Enzyme Inhibitors / pharmacology
- Animals
- Blood Pressure / drug effects
- Blood Pressure / physiology
- Captopril / administration & dosage
- Captopril / pharmacology
- Dose-Response Relationship, Drug
- Enalapril / administration & dosage
- Enalapril / pharmacology
- Enalaprilat / administration & dosage
- Enalaprilat / pharmacology
- Female
- Hemodynamics / drug effects
- Hemodynamics / physiology
- Horses / blood
- Injections, Intravenous / veterinary
- Male
- Peptidyl-Dipeptidase A / blood
- Renin-Angiotensin System / drug effects
- Renin-Angiotensin System / physiology
Citations
This article has been cited 1 times.- Costa MF, Carmona AK, Alves MF, Ryan TM, Davies HM, Anderson GA, Slocombe RF. Determination of angiotensin I-converting enzyme activity in equine blood: lack of agreement between methods of analysis. J Vet Sci 2011 Mar;12(1):21-5.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists
